JP2025510336A5 - - Google Patents

Info

Publication number
JP2025510336A5
JP2025510336A5 JP2024557570A JP2024557570A JP2025510336A5 JP 2025510336 A5 JP2025510336 A5 JP 2025510336A5 JP 2024557570 A JP2024557570 A JP 2024557570A JP 2024557570 A JP2024557570 A JP 2024557570A JP 2025510336 A5 JP2025510336 A5 JP 2025510336A5
Authority
JP
Japan
Prior art keywords
seq
region
antigen
nucleic acid
scfv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557570A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510336A (ja
Filing date
Publication date
Priority claimed from EP22382294.1A external-priority patent/EP4253418A1/en
Application filed filed Critical
Publication of JP2025510336A publication Critical patent/JP2025510336A/ja
Publication of JP2025510336A5 publication Critical patent/JP2025510336A5/ja
Pending legal-status Critical Current

Links

JP2024557570A 2022-03-29 2023-03-28 キメラ抗原受容体及び二重特異性抗体を発現する免疫細胞及びその使用 Pending JP2025510336A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22382294.1 2022-03-29
EP22382294.1A EP4253418A1 (en) 2022-03-29 2022-03-29 Immune cells expressing chimeric antigen receptors and bispecific antibodies and uses thereof
PCT/EP2023/057957 WO2023186873A1 (en) 2022-03-29 2023-03-28 Immune cells expressing chimeric antigen receptors and bispecific antibodies and uses thereof

Publications (2)

Publication Number Publication Date
JP2025510336A JP2025510336A (ja) 2025-04-14
JP2025510336A5 true JP2025510336A5 (https=) 2026-04-07

Family

ID=81326113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557570A Pending JP2025510336A (ja) 2022-03-29 2023-03-28 キメラ抗原受容体及び二重特異性抗体を発現する免疫細胞及びその使用

Country Status (6)

Country Link
US (1) US20250186588A1 (https=)
EP (2) EP4253418A1 (https=)
JP (1) JP2025510336A (https=)
CN (1) CN119256011A (https=)
CA (1) CA3255076A1 (https=)
WO (1) WO2023186873A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22545A1 (es) 1994-11-18 1999-03-31 Centro Inmunologia Molecular Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
US4943533A (en) 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
US4694778A (en) 1984-05-04 1987-09-22 Anicon, Inc. Chemical vapor deposition wafer boat
EP0491007B1 (en) 1989-09-08 1996-03-13 The Johns Hopkins University Structural alterations of the egf receptor gene in human gliomas
DE69428764T2 (de) 1993-12-24 2002-06-20 Merck Patent Gmbh Immunokonjugate
JPH11507535A (ja) 1995-06-07 1999-07-06 イムクローン システムズ インコーポレイテッド 腫瘍の成長を抑制する抗体および抗体フラグメント類
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
DE10143237A1 (de) 2001-09-04 2003-03-20 Icon Genetics Ag Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente)
US20050112095A1 (en) 2002-07-09 2005-05-26 Tsu-An Hsu Internal ribosome entry sites for recombinant protein expression
SI1934174T1 (sl) 2005-10-07 2011-08-31 Exelixis Inc Inhibitorji MEK in postopki za njihovo uporabo
ES2342646B1 (es) 2008-06-02 2011-04-26 Institut De Recerca Hospital Universitari Vall Hebron Metodo de diagnostico de canceres que expresan el receptor her-2 o sus variantes truncadas.
GB0906576D0 (en) 2009-04-16 2009-05-20 Animal Health Inst Internal ribosome entry site
WO2018085690A1 (en) 2016-11-04 2018-05-11 Bluebird Bio, Inc. Anti-bcma car t cell compositions
EP3915576A1 (en) 2020-05-28 2021-12-01 Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron Chimeric antigen receptors specific for p95her2 and uses thereof

Similar Documents

Publication Publication Date Title
JP2021087455A5 (https=)
JP2021094037A5 (https=)
JP2025028239A5 (https=)
FI4063397T3 (fi) Yksidomeenivasta-aineisiin perustuvia antigeenireseptoreita ja menetelmiä niiden käyttämiseksi
JP2025065142A5 (https=)
JP2022514693A5 (https=)
JP2019527557A5 (https=)
JP2022542543A5 (https=)
JP2021526844A5 (https=)
JP7503642B2 (ja) 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法
JP2025142045A5 (https=)
JP2019527537A5 (https=)
JP2018533371A5 (https=)
KR20230143177A (ko) 신규한 항-cd24 항체
JP2020512973A5 (https=)
JP2021516951A5 (https=)
JP2022542559A5 (https=)
JP2022523710A5 (https=)
JP2022547552A5 (https=)
JP2024504162A5 (https=)
JP2024539630A5 (https=)
JP2024516098A5 (https=)
JP2023554467A5 (https=)
JP2024541476A5 (https=)
JP7496093B2 (ja) CARライブラリおよびscFvの製造方法